Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
13.1M
-
Number of holders
-
29
-
Total 13F shares, excl. options
-
5.03M
-
Shares change
-
+759K
-
Total reported value, excl. options
-
$39.3M
-
Value change
-
+$4.7M
-
Number of buys
-
13
-
Number of sells
-
-6
-
Price
-
$7.76
Significant Holders of Forte Biosciences, Inc. - Common Stock, $0.001 par value (FBRX) as of Q1 2025
31 filings reported holding FBRX - Forte Biosciences, Inc. - Common Stock, $0.001 par value as of Q1 2025.
Forte Biosciences, Inc. - Common Stock, $0.001 par value (FBRX) has 29 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5.03M shares
of 13.1M outstanding shares and own 38.52% of the company stock.
Largest 10 shareholders include JANUS HENDERSON GROUP PLC (920K shares), FRED ALGER MANAGEMENT, LLC (911K shares), TYBOURNE CAPITAL MANAGEMENT (HK) LTD (620K shares), Ikarian Capital, LLC (609K shares), BVF INC/IL (594K shares), ORBIMED ADVISORS LLC (593K shares), Cable Car Capital, LP (220K shares), Woodline Partners LP (205K shares), BOOTHBAY FUND MANAGEMENT, LLC (89.2K shares), and VANGUARD GROUP INC (89K shares).
This table shows the top 29 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.